Daniel G. Welch - Feb 2, 2023 Form 3 Insider Report for Structure Therapeutics Inc. (GPCR)

Role
Director
Signature
/s/ Daniel G. Welch
Stock symbol
GPCR
Transactions as of
Feb 2, 2023
Transactions value $
$0
Form type
3
Date filed
2/2/2023, 05:23 PM
Previous filing
Jun 28, 2022
Next filing
Feb 9, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GPCR Series B Preferred Shares Feb 2, 2023 Ordinary Shares 124K By spouse F1
holding GPCR Stock option (right to buy) Feb 2, 2023 Ordinary Shares 1.18M $2.60 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All outstanding Preferred Shares will automatically convert into Ordinary Shares immediately upon the closing of Issuer's initial public offering, for no additional consideration at a rate of one Ordinary Share for each one Preferred Share, based on the conversion price currently in effect. The Preferred Shares have no expiration date.
F2 1/3rd of the shares shall vest one year after January 5, 2022 (the "Vesting Commencement Date"); the balance of the shares vest in a series of 24 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.